Q4 2017 13F Holders as of 31 Dec 2017
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
111,111,111
-
Number of holders
-
122
-
Total 13F shares, excl. options
-
37,382,594
-
Shares change
-
+628,198
-
Total reported value, excl. options
-
$755,132,400
-
Value change
-
+$13,375,574
-
Put/Call ratio
-
22.45%
-
Number of buys
-
70
-
Number of sells
-
-35
-
Price
-
$20.2
Significant Holders of NovoCure Ltd - Common Stock (NVCR) as of Q4 2017
146 filings reported holding NVCR - NovoCure Ltd - Common Stock as of Q4 2017.
NovoCure Ltd - Common Stock (NVCR) has 122 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 37,382,594 shares
of 111,111,111 outstanding shares and own 33.64% of the company stock.
Largest 10 shareholders include FMR LLC (8,066,199 shares), Vanguard Group Inc (4,606,070 shares), BlackRock Inc. (3,806,096 shares), StepStone Group LP (1,615,479 shares), HIGHLINE CAPITAL MANAGEMENT, L.P. (1,474,610 shares), FARALLON CAPITAL MANAGEMENT LLC (1,165,000 shares), STATE STREET CORP (1,131,968 shares), FRONTIER CAPITAL MANAGEMENT CO LLC (1,081,898 shares), WADDELL & REED FINANCIAL INC (882,940 shares), and GREAT POINT PARTNERS LLC (879,286 shares).
This table shows the top 122 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.